Summary
- Current Price
- As of today, GANX price is $1.80, down -1.64% on
- Current Price All-Time High
- GANX price is currently -89.96% below its historical high of $17.93 set on
- Market Cap
- GANX current market cap is $69M, up +26.09% over the past 365 days
- PE Ratio
- GANX PE ratio is unknown
- Revenue
- GANX current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- As of today, the next earnings release for GANX has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Gain Therapeutics, Inc. |
| Ticker | NASDAQ: GANX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | gaintherapeutics.com |
| Employees | 23 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $1.80 | ||
| Price, 1D Change | -1.64% | |
| $69M | ||
| - | ||
| - | ||
| 1.08 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$0.61 | ||
| EPS, 1Y Change | +31.45% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$0.61 | ||
| EPS Estimate | N/A | -$0.66 |
| EPS Est. Change | N/A | -8.47% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| $1.80 | ||
| Price Target | - | $8.00 |
| Price Tgt. Change | - | +344.44% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.00 | -$0.89 | +11.02% | |
| -$0.65 | -$0.61 | +5.19% | |
| -$0.66 | N/A | -8.47% | |
| -$0.74 | N/A | -21.01% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| -5.76% | ||
| -62.66% | ||
| +26.09% | ||
| +18.83% | ||
| 0.00% | ||
| -100.00% | ||
| +31.45% | ||
| +58.69% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $1.80 | ||
| $2.16 | ||
| SMA 200 vs Price | +19.80% | |
| $2.13 | ||
| SMA 50 vs Price | +18.32% | |
| 1.08 | ||
| $0.22 | ||
| 37.69 | ||
| 136.38% | ||
| 110.65% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$0.61 | ||
| $0.00 | ||
| - | ||
| -$18.71M | ||
| - | ||
| -$20.16M | ||
| - | ||
| -$18.62M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.04 | ||
| 6.63 | ||
| 6.63 | ||
| - | ||
| - | ||
| 1.83 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 3.73 | ||
| -2.64 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $18.56M | ||
| $20.84M | ||
| $22.82M | ||
| $22.24M | ||
| $4.25M | ||
| $3.35M | ||
| $732.10K | ||
| $220.70K | ||
| $825.00K |
Expenses
| Metric | Date | Value |
|---|---|---|
| $20.16M | ||
| $18.71M | ||
| $94.00K | ||
| $0.00 | ||
| $94.00K | ||
| $0.00 | ||
| $861.10K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$18.47M | ||
| $0.00 | ||
| $28.45M | ||
| $0.00 | ||
| -$18.47M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| BTIG | → | |
| HC Wainwright & Co. | → | |
| Maxim Group | → | |
| BTIG | → | |
| Roth Capital | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Chardan Capital | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with GANX
FAQ
What is the ticker symbol for Gain Therapeutics, Inc.?
The ticker symbol for Gain Therapeutics, Inc. is NASDAQ:GANX
Does Gain Therapeutics, Inc. pay dividends?
No, Gain Therapeutics, Inc. does not pay dividends
What sector is Gain Therapeutics, Inc. in?
Gain Therapeutics, Inc. is in the Healthcare sector
What industry is Gain Therapeutics, Inc. in?
Gain Therapeutics, Inc. is in the Biotechnology industry
What country is Gain Therapeutics, Inc. based in?
Gain Therapeutics, Inc. is headquartered in United States
When did Gain Therapeutics, Inc. go public?
Gain Therapeutics, Inc. initial public offering (IPO) was on March 19, 2021
Is Gain Therapeutics, Inc. in the S&P 500?
No, Gain Therapeutics, Inc. is not included in the S&P 500 index
Is Gain Therapeutics, Inc. in the NASDAQ 100?
No, Gain Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Gain Therapeutics, Inc. in the Dow Jones?
No, Gain Therapeutics, Inc. is not included in the Dow Jones index
When was Gain Therapeutics, Inc. last earnings report?
Gain Therapeutics, Inc.'s most recent earnings report was on March 25, 2025
When does Gain Therapeutics, Inc. report earnings?
The date for Gain Therapeutics, Inc.'s next earnings report has not been announced yet
Data Sources & References
- GANX Official Website gaintherapeutics.com
- GANX Profile on Yahoo Finance finance.yahoo.com/quote/GANX
- GANX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/ganx